期刊文献+

综合疗法治疗特发性少弱精子症120例观察 被引量:3

Observation on treating 120 cases of idiopathic oligoasthenospermia by combination therapy
下载PDF
导出
摘要 目的:综合疗法治疗特发性少弱精子症的疗效观察。方法:采用分度诊断标准和分度疗效标准对综合疗法治疗特发性少弱精子症120例的疗效进行评估。结果:①少精子症的总有效率52.5%(63/120),良效率19.17%(23/120),有效率33.33%(40/120),无效率47.5%(57/120)。②弱精子症的总有效率37.5%(45/120),良效率10%(12/120例),有效率27.5%(33/120例),无效率62.5%(75/120例)。结论:采用分度评估,观察临床治疗药物对精液质量改善的疗效,不但客观的评价药物治疗特发性少弱精子症的效果,更重要的是其分度诊断标准和分度疗效标准能为今后治疗少弱精子症的疗效评估和疗效统计走向科学化、规范化、标准化提供重要的参考依据。其治疗结果虽较以往经验治疗的疗效有所提高,但离患者的期望还有相当大的差距,男科工作者还应该积极探索更好的治疗方法,提高疗效,使男性不育的治疗能有一个大的突破。 Objective: To effects observe of treating idiopathic oligoasthenospermia by combination therapy. Methods: Taking the indexing diagnosis standard and indexing effect standard the effect assess of treating idiopathic oligoasthenospermia by combination therapy. Result: ①The total efficiency 52.5% (63/120) of oligozoospermia, good efficiency 10% (12/120 cases), efficiency 27.5% (33/120 cases), inefficiency 62.5% (75/120 cases). Conclusion: Taking indexing assess, to observe effects improve of semen quality with medicine. Treatment result was improved, but the expect have a difference. Improve the efficacy, make to treating male infertility have a large break through.
出处 《中医临床研究》 2010年第12期92-93,96,共3页 Clinical Journal Of Chinese Medicine
关键词 评估 不育症 疗效 Assess Sterility Effective
  • 相关文献

参考文献5

  • 1世界卫生组织.男子不育标准化诊疗手册[M].上海:第二届亚太男科学术论坛冀男性不育规范化培训讲义.(李铮等译),2006.
  • 2谷翊群,陈振文等译.人类精液及精子-宫颈粘液相互作用实验室检验手册[M].世界卫生组织人民卫生出版社出版,2001.
  • 3Comhaire F.Tredtment of oligospermia with Tamoxifen[M].IntFertil, 1976,2:232.
  • 4The ESHRE Capri Workshop Group.Male infertility update[M].Hum Repr-od, 1998,13(7):2025-2032.
  • 5王益鑫,郑菊芬.男性不育研究新进展[J].中华男科学杂志,2006,12(9):771-774. 被引量:58

二级参考文献9

  • 1The ESHRE Capri Workshop Group. Male infertility update[J].Hum Reprod, 1998, 13(7):2025-2032.
  • 2Dohle GR, Smit M. Microsurgical vasovasostomy at the Erasmus MC, 1998-2002: results and predictive factors[J]. Ned Tijdschr Geneeskd, 2005, 149(49) : 2743-2747.
  • 3Meng MV, Greene KL, Turek PJ. Surgery or assisted reproduction? A decision analysis of treatment costs in male infertility[J].J Urol, 2005, 174(5) : 1926-1931.
  • 4Devroey P, Van Steirteghem A. A review of ten years experience of ICSI[J] . Hum Reprod Update, 2004, 10( 1 ) : 19-28.
  • 5Carrell DT, De Jonge C, Lamb DJ. The genetics of male infertility: a field of study whose time is now[J]. Arch Androl, 2006,52(4) :269-274.
  • 6Schlegel PN, Cohen J, Goldstein M, et al. Cystic fibrosis gene mutations do not affect sperm function during in vitro fertilization with micromanipulation for men with bilateral congential absence of vas deferens[J]. Fertil Steril, 1995, 64(2) :421-426.
  • 7Wu CC, Alper OM, Lu JF, et al. Mutation spectrum of the CFTR gene in Taiwan Residents patients with congenital bilateral absence of the vas deferens[ J]. Hum Reprod, 2005,20(9) :2470-2475.
  • 8Krausz C, Degi.Innocenti S. Y chromosome and male infertility:update, 2006 [ J ]. Front Biosci, 2006, 11:3049-3061.
  • 9Schegel PN. Debate: Is ICSI a genetic time bomb? No: ICSI is safe and effective[J]. J Androl, 1999, 20(1) :18-22.

共引文献57

同被引文献52

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部